BROKERS CHOICE: BEL, HINDALCO, DIXON, ZYDUSLIFE, CMSINFO, TORRENTPHARMA, GLANDPHARMA, USL

MUMBAI. 21 MAY: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

Macquarie on BEL: Maintain Outperform on Company, raise target price at Rs 400 versus Rs 365 (Positive)

CLSA on BEL: Maintain Outperform on Company, raise target price at Rs 423 (Positive)

MS on BEL: Maintain Overweight on Company, raise target price at Rs 418 versus Rs 364 (Positive)

JP Morgan on Hindalco: Maintain Overweight on Company, raise target price at Rs 720 versus Rs 680 (Positive)

CLSA on Hindalco: Maintain Buy on Company, raise target price at Rs 850 (Positive)

Nomura on Dixon Tech: Maintain Buy on Company, raise target price at Rs 21202 (Positive)

CLSA on Dixon Tech: Maintain Outperform on Company, raise target price at Rs 19000 (Positive)

Nomura on Zydus Life: Maintain Buy on Company, target price at Rs 1140 (Positive)

Macquarie on Zydus Life: Maintain Outperform on Company, target price at Rs 1365 (Positive)

Nuvama on USL: Maintain Buy on Company, target price at Rs 1820 (Positive)

Jefferies on CMS Info: Maintain Buy on Company, cut target price at Rs 580 (Neutral)

Jefferies on Torrent Pharma: Maintain Buy on Company, cut target price at Rs 3740 (Neutral)

Citi on Torrent Pharma: Maintain Buy on Company, target price at Rs 4000 (Neutral)

Nuvama on Torrent Pharma: Maintain Buy on Company, target price at Rs 3760 (Neutral)

Nomura on Gland Pharma: Maintain Neutral on Company, target price at Rs 1570 (Neutral)

MS on Dixon Tech: Maintain Equal weight on Company, target price at Rs 8696 (Neutral)

Nuvama on Siemens: Maintain Hold on Company, target price at Rs 3170 (Neutral)

Citi on Zydus Life: Maintain Sell on Company, target price at Rs 900 (Neutral)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)